EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
EydisBio has raised $500K in total funding. The most recent round was Grant. The last funding was announced in October 2024.
EydisBio's investors include National Institute on Aging, National Heart, Lung and Blood Institute, One North Carolina Small Business Program.
EydisBio is headquartered in Durham, United States.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
EydisBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EydisBio — Funding & Investors." VCBacked, October 23, 2024, https://www.vcbacked.co/company/eydisbio. Accessed September 30, 2026.
VCBacked. (2024). EydisBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/eydisbio
{{cite web |title=EydisBio — Funding & Investors |url=https://www.vcbacked.co/company/eydisbio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated